Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, August 11, 2022
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
[ Thu, Aug 11th 2022
] - WOPRAI
Daina Graybosch Downgraded (BOLT) to Hold and Decreased Target to $4 on, Aug 11th, 2022
Daina Graybosch of SVB Leerink, Downgraded "Bolt Biotherapeutics, Inc." (BOLT) to Hold and Decreased Target from $8 to $4 on, Aug 11th, 2022.
Daina has made no other calls on BOLT in the last 4 months.
There is 1 other peer that has a rating on BOLT. Out of the 1 peers that are also analyzing BOLT, all agrees with Daina's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Decreased Target to $5 on, Tuesday, May 17th, 2022
